These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 19693982

  • 1. [Transforming growth factor-beta and its receptors in scleroderma].
    QIAN H, ZHENG M.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):415-21. PubMed ID: 19693982
    [Abstract] [Full Text] [Related]

  • 2. Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model.
    Chujo S, Shirasaki F, Kawara S, Inagaki Y, Kinbara T, Inaoki M, Takigawa M, Takehara K.
    J Cell Physiol; 2005 May; 203(2):447-56. PubMed ID: 15605379
    [Abstract] [Full Text] [Related]

  • 3. Role of PDGF in fibrotic diseases and systemic sclerosis.
    Trojanowska M.
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v2-4. PubMed ID: 18784131
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N.
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis.
    Verrecchia F, Mauviel A, Farge D.
    Autoimmun Rev; 2006 Oct; 5(8):563-9. PubMed ID: 17027893
    [Abstract] [Full Text] [Related]

  • 6. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T, Kähäri VM, Black C, Vuorio E.
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [Abstract] [Full Text] [Related]

  • 7. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK, Bhattacharyya S, Lakos G, Chen SJ, Mori Y, Varga J.
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of skin fibrosis in systemic sclerosis.
    Jinnin M.
    J Dermatol; 2010 Jan; 37(1):11-25. PubMed ID: 20175837
    [Abstract] [Full Text] [Related]

  • 9. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
    Distler JH, Jüngel A, Huber LC, Schulze-Horsel U, Zwerina J, Gay RE, Michel BA, Hauser T, Schett G, Gay S, Distler O.
    Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
    Distler JH, Jüngel A, Pileckyte M, Zwerina J, Michel BA, Gay RE, Kowal-Bielecka O, Matucci-Cerinic M, Schett G, Marti HH, Gay S, Distler O.
    Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
    [Abstract] [Full Text] [Related]

  • 11. Upregulated expression of transforming growth factor-beta receptors in dermal fibroblasts of skin sections from patients with systemic sclerosis.
    Kubo M, Ihn H, Yamane K, Tamaki K.
    J Rheumatol; 2002 Dec; 29(12):2558-64. PubMed ID: 12465152
    [Abstract] [Full Text] [Related]

  • 12. Extracellular proteoglycans modify TGF-beta bio-availability attenuating its signaling during skeletal muscle differentiation.
    Droguett R, Cabello-Verrugio C, Riquelme C, Brandan E.
    Matrix Biol; 2006 Aug; 25(6):332-41. PubMed ID: 16766169
    [Abstract] [Full Text] [Related]

  • 13. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1.
    Yamamoto T, Eckes B, Krieg T.
    Biochem Biophys Res Commun; 2001 Feb 16; 281(1):200-5. PubMed ID: 11178980
    [Abstract] [Full Text] [Related]

  • 14. TGF beta--a role in systemic sclerosis?
    Cotton SA, Herrick AL, Jayson MI, Freemont AJ.
    J Pathol; 1998 Jan 16; 184(1):4-6. PubMed ID: 9582519
    [Abstract] [Full Text] [Related]

  • 15. Altered dynamics of transforming growth factor β(TGF-β) receptors in scleroderma fibroblasts.
    Asano Y, Ihn H, Jinnin M, Tamaki K, Sato S.
    Ann Rheum Dis; 2011 Feb 16; 70(2):384-7. PubMed ID: 21081531
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-beta 1 and collagen gene expression during postnatal skin development and fibrosis in the tight-skin mouse.
    Pablos JL, Everett ET, Harley R, LeRoy EC, Norris JS.
    Lab Invest; 1995 Jun 16; 72(6):670-8. PubMed ID: 7783425
    [Abstract] [Full Text] [Related]

  • 17. Scleroderma, fibroblasts, signaling, and excessive extracellular matrix.
    Ihn H.
    Curr Rheumatol Rep; 2005 Apr 16; 7(2):156-62. PubMed ID: 15760596
    [Abstract] [Full Text] [Related]

  • 18. Connective tissue growth factor: growth factor, matricellular organizer, fibrotic biomarker or molecular target for anti-fibrotic therapy in SSc?
    Abraham D.
    Rheumatology (Oxford); 2008 Oct 16; 47 Suppl 5():v8-9. PubMed ID: 18784153
    [Abstract] [Full Text] [Related]

  • 19. Induction of cardiac fibrosis by transforming growth factor-beta(1).
    Lijnen PJ, Petrov VV, Fagard RH.
    Mol Genet Metab; 2000 Oct 16; 71(1-2):418-35. PubMed ID: 11001836
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor-beta: a key mediator of fibrosis.
    Mauviel A.
    Methods Mol Med; 2005 Oct 16; 117():69-80. PubMed ID: 16118446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.